<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">jxdf98kXJMKN7jPC9vkjS7r</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2012001100007</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(12)09900207</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012005000067</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Disfun&#231;&#227;o auton&#244;mica e anticorpos contra receptores anti-m2 e anti-&#946;1 em pacientes chag&#225;sicos</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Thiers</surname>
            <given-names>Clarissa Antunes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>Jo&#227;o Luis</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Bas&#237;lio de Bragan&#231;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento</surname>
            <given-names>Em&#237;lia Matos do</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento</surname>
            <given-names>Jos&#233; Hamilton do</given-names>
          </name>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medei</surname>
            <given-names>Emiliano Hor&#225;cio</given-names>
          </name>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pedrosa</surname>
            <given-names>Roberto Coury</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff05">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <institution content-type="orgdiv1">Instituto de Biof&#237;sica Carlos Chagas Filho </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Instituto Nacional de Cardiologia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Servi&#231;o de Bioestat&#237;stica e Estat&#237;stica Aplicada</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <institution content-type="orgdiv1">Instituto Alberto Luiz Coimbra de P&#243;s-Gradua&#231;&#227;o e Pesquisa de Engenharia </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <institution content-type="orgdiv1">Instituto de Cardiologia Edson Saad </institution>
        <institution content-type="orgdiv2">Hospital Universit&#225;rio Clementino Fraga Filho</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>08</month>
        <year>2012</year>
      </pub-date>
      <volume>99</volume>
      <issue>2</issue>
      <fpage>732</fpage>
      <lpage>739</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>01</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>02</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>01</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A morte s&#250;bita &#233; a principal causa de &#243;bito na doen&#231;a de Chagas, acometendo pacientes mesmo em fases precoces da doen&#231;a. &#201; reconhecido o comprometimento do sistema nervoso aut&#244;nomo nessa doen&#231;a e seu potencial como deflagrador de arritmias malignas quando associado a altera&#231;&#245;es estruturais ou metab&#243;licas. OBJETIVO: Buscamos identificar, em pacientes chag&#225;sicos com fun&#231;&#227;o sist&#243;lica preservada, o comprometimento do sistema nervoso aut&#244;nomo e sua associa&#231;&#227;o com anticorpos funcionalmente ativos contra receptores anti-m2 e anti-&#946;1. M&#201;TODOS: Mediante an&#225;lise espectral da variabilidade RR durante teste de inclina&#231;&#227;o passiva, pacientes chag&#225;sicos cr&#244;nicos foram comparados com controles saud&#225;veis pareados por idade. Posteriormente, a associa&#231;&#227;o de disfun&#231;&#227;o auton&#244;mica com anticorpos funcionalmente ativos com a&#231;&#227;o anti-m2 e anti-&#946;1 foi pesquisada pelo m&#233;todo de Langendorf. RESULTADOS: Observamos que pacientes chag&#225;sicos sem disfun&#231;&#227;o ventricular expressam atividade parassimp&#225;tica ante um est&#237;mulo vagal, por&#233;m com menor intensidade em rela&#231;&#227;o aos controles. Pacientes chag&#225;sicos com anticorpos anti-m2 ou anti-&#946;1 apresentaram uma redu&#231;&#227;o ainda mais expressiva da resposta vagal durante a arritmia sinusal respirat&#243;ria, independentemente da presen&#231;a de les&#227;o estrutural. Entretanto, a associa&#231;&#227;o de ambos promoveu resposta ao est&#237;mulo vagal similar aos chag&#225;sicos sem a presen&#231;a dos mesmos. CONCLUS&#195;O: A menor reserva vagal em pacientes chag&#225;sicos com fun&#231;&#227;o preservada esteve associada &#224; presen&#231;a de anticorpos anti-m2 ou anti-&#946;1 funcionalmente ativos, e n&#227;o &#224; presen&#231;a de les&#227;o card&#237;aca estrutural.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;a de Chagas</kwd>
        <kwd>denerva&#231;&#227;o aut&#244;noma</kwd>
        <kwd>anticorpos</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>13</day>
        <month>07</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Disfun&#231;&#227;o auton&#244;mica e anticorpos contra receptores anti-m2 e anti-</bold>
      <bold>&#946;</bold>
      <bold>1 em pacientes chag&#225;sicos</bold>
    </p>
    <p>
      <bold>Clarissa Antunes Thiers<sup>I, II</sup>; Jo&#227;o Luis Barbosa<sup>I, II</sup>; Bas&#237;lio de Bragan&#231;a Pereira<sup>II, IV</sup>; Em&#237;lia Matos do Nascimento<sup>III</sup>; Jos&#233; Hamilton do Nascimento<sup>V</sup>; Emiliano Hor&#225;cio Medei<sup>V</sup>; Roberto Coury Pedrosa<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Instituto Nacional de Cardiologia - Rio de Janeiro, RJ - Brazil </p>
    <p><sup>II</sup>Servi&#231;o de Cardiologia, Hospital Universit&#225;rio Clementino Fraga Filho / Instituto de Cardiologia Edson Saad - UFRJ - Rio de Janeiro, RJ - Brazil </p>
    <p><sup>III</sup>Instituto Alberto Luiz Coimbra de P&#243;s-Gradua&#231;&#227;o e Pesquisa de Engenharia, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brazil </p>
    <p><sup>IV</sup>Servi&#231;o de Bioestat&#237;stica e Estat&#237;stica Aplicada, Faculdade de Medicina, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brazil </p>
    <p><sup>V</sup>Instituto de Biof&#237;sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A morte s&#250;bita &#233; a principal causa de &#243;bito na doen&#231;a de Chagas, acometendo pacientes mesmo em fases precoces da doen&#231;a. &#201; reconhecido o comprometimento do sistema nervoso aut&#244;nomo nessa doen&#231;a e seu potencial como deflagrador de arritmias malignas quando associado a altera&#231;&#245;es estruturais ou metab&#243;licas. </p>
    <p><bold>OBJETIVO: </bold> Buscamos identificar, em pacientes chag&#225;sicos com fun&#231;&#227;o sist&#243;lica preservada, o comprometimento do sistema nervoso aut&#244;nomo e sua associa&#231;&#227;o com anticorpos funcionalmente ativos contra receptores anti-m2 e anti-&#946;1. </p>
    <p><bold>M&#201;TODOS: </bold> Mediante an&#225;lise espectral da variabilidade RR durante teste de inclina&#231;&#227;o passiva, pacientes chag&#225;sicos cr&#244;nicos foram comparados com controles saud&#225;veis pareados por idade. Posteriormente, a associa&#231;&#227;o de disfun&#231;&#227;o auton&#244;mica com anticorpos funcionalmente ativos com a&#231;&#227;o anti-m2 e anti-&#946;1 foi pesquisada pelo m&#233;todo de Langendorf. </p>
    <p><bold>RESULTADOS: </bold> Observamos que pacientes chag&#225;sicos sem disfun&#231;&#227;o ventricular expressam atividade parassimp&#225;tica ante um est&#237;mulo vagal, por&#233;m com menor intensidade em rela&#231;&#227;o aos controles. Pacientes chag&#225;sicos com anticorpos anti-m2 ou anti-&#946;1 apresentaram uma redu&#231;&#227;o ainda mais expressiva da resposta vagal durante a arritmia sinusal respirat&#243;ria, independentemente da presen&#231;a de les&#227;o estrutural. Entretanto, a associa&#231;&#227;o de ambos promoveu resposta ao est&#237;mulo vagal similar aos chag&#225;sicos sem a presen&#231;a dos mesmos. </p>
    <p><bold>CONCLUS&#195;O: </bold> A menor reserva vagal em pacientes chag&#225;sicos com fun&#231;&#227;o preservada esteve associada &#224; presen&#231;a de anticorpos anti-m2 ou anti-&#946;1 funcionalmente ativos, e n&#227;o &#224; presen&#231;a de les&#227;o card&#237;aca estrutural.</p>
    <p><bold>Palavras-chave: </bold> Doen&#231;a de Chagas; denerva&#231;&#227;o aut&#244;noma; anticorpos.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Cem anos ap&#243;s a sua descri&#231;&#227;o por Carlos Chagas em 1909, a Doen&#231;a de Chagas (DC) ainda representa um desafio &#224;s Organiza&#231;&#245;es de Sa&#250;de. Segundo dados da Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS), ainda que a transmiss&#227;o vetorial tenha sido interrompida em pa&#237;ses como Brasil, Chile e Uruguai, a preval&#234;ncia de doentes com cardiopatia chag&#225;sica cr&#244;nica foi estimada em 18 a 20 milh&#245;es de indiv&#237;duos na Am&#233;rica Latina, com 300 mil novos casos a cada ano, e 50 mil mortes anuais associadas &#224; doen&#231;a<sup>1</sup>. No Brasil, atualmente predominam os casos cr&#244;nicos da doen&#231;a, com aproximadamente tr&#234;s milh&#245;es de indiv&#237;duos infectados<sup>2</sup>.</p>
    <p>N&#227;o h&#225; evid&#234;ncias suficientes para suportar a necessidade de tratamento imediato em todo paciente chag&#225;sico cr&#244;nico que apresenta fun&#231;&#227;o preservada, embora haja estudos sugerindo um aumento na morbimortalidade nesse grupo de pacientes<sup>3-11</sup>. Uma recente revis&#227;o tem sugerido que em pacientes nessa forma de apresenta&#231;&#227;o card&#237;aca (ECG alterado e altera&#231;&#227;o regional ao ecocardiograma, por&#233;m com fun&#231;&#227;o ventricular preservada), a necessidade de futura avalia&#231;&#227;o deve ser julgada em bases individuais<sup>11</sup>. A I Diretriz Latino-Americana para o diagn&#243;stico e tratamento da cardiopatia chag&#225;sica, recentemente publicada, igualmente reconhece a exist&#234;ncia desse grupo de pacientes e seu valor progn&#243;stico para morte s&#250;bita<sup>12</sup>.</p>
    <p>Nas &#250;ltimas d&#233;cadas, in&#250;meros trabalhos t&#234;m elucidado uma rela&#231;&#227;o entre o Sistema Nervoso Aut&#244;nomo (SNA) e a fun&#231;&#227;o imunol&#243;gica, e t&#234;m contribu&#237;do para desvendar alguns mecanismos envolvidos nessa intera&#231;&#227;o. Na cardiopatia chag&#225;sica cr&#244;nica, nosso grupo tem participa&#231;&#227;o ativa nesse sentido<sup>13-18</sup>. &#201; poss&#237;vel que anticorpos circulantes funcionalmente ativos, contra receptores acoplados &#224; prote&#237;na G capazes de interferir com receptores de ambos os sistemas, parassimp&#225;tico e simp&#225;tico, afetem fisiopatologicamente o comportamento auton&#244;mico card&#237;aco e modulem propriedades eletrofisiol&#243;gicas envolvidas em mecanismos de arritmias ventriculares complexas<sup>18-20</sup>. Tais anticorpos n&#227;o s&#227;o mero epifen&#244;meno da destrui&#231;&#227;o do sistema nervoso aut&#244;nomo e s&#227;o independentes das les&#245;es card&#237;acas<sup>14,20-23</sup>. Recentemente, mostramos que, no paciente chag&#225;sico com fun&#231;&#227;o sist&#243;lica preservada, a modula&#231;&#227;o auton&#244;mica simp&#225;tica card&#237;aca &#233; afetada. Isso foi demonstrado pela destrui&#231;&#227;o do nervo card&#237;aco que ocorreu em &#226;mbito ventricular demonstrado pela cintilografia com <sup>123</sup>I-MIBG<sup>23</sup>.</p>
    <p>Estudos da variabilidade RR (VRR) t&#234;m sido estabelecidos como real e reproduz&#237;vel marcador de fun&#231;&#227;o auton&#244;mica cardiovascular<sup>24</sup>. Dentre as manobras para avalia&#231;&#227;o da resposta parassimp&#225;tica, a Arritmia Sinusal Respirat&#243;ria (ASR) tem demonstrado ser o est&#237;mulo mais potente para evocar a a&#231;&#227;o do nervo vago<sup>25,26</sup>. Na doen&#231;a de Chagas, no grupo sem disfun&#231;&#227;o ventricular, a avalia&#231;&#227;o do sistema nervoso aut&#244;nomo por meio da VRR por diferentes m&#233;todos tem evidenciado comprometimento vari&#225;vel da modula&#231;&#227;o parassimp&#225;tica e simp&#225;tica<sup>27-30</sup>. No presente estudo buscamos identificar, dentre os pacientes chag&#225;sicos sem disfun&#231;&#227;o ventricular, aqueles com altera&#231;&#227;o da modula&#231;&#227;o auton&#244;mica vagal sobre a VRR em resposta &#224; ASR e &#224; manobra de estimula&#231;&#227;o simp&#225;tica fisiol&#243;gica (inclina&#231;&#227;o passiva a 70&#176;), e correlacion&#225;-la &#224; presen&#231;a de anticorpos funcionalmente ativos contra receptores card&#237;acos muscar&#237;nicos m2 e adren&#233;rgico &#946;1.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Trata-se de um estudo de s&#233;rie de casos realizado entre outubro/2009 e agosto/2010. A sele&#231;&#227;o dos pacientes foi feita no ambulat&#243;rio de cardiopatia chag&#225;sica do Hospital Universit&#225;rio Clementino Fraga Filho - UFRJ/HUCFF. De 310 indiv&#237;duos acompanhados regularmente, 76 pacientes que tiveram os soros caracterizados para a presen&#231;a de anticorpos funcionalmente ativos contra receptores acoplados &#224; prote&#237;na G (anti-m2 e/ou anti-&#946;1) foram selecionados. Foram exclu&#237;dos do estudo 35 pacientes com doen&#231;as cr&#244;nicas, especialmente cardiovasculares; com Fra&#231;&#227;o de Eje&#231;&#227;o (FE) menor que 50%; arritmias card&#237;acas frequentes e/ou ritmos n&#227;o sinusais; diabete melito; doen&#231;a de Parkinson ou neuropatias; pacientes em uso de medica&#231;&#245;es que pudessem interferir com o sistema cardiovascular, com doen&#231;a pulmonar obstrutiva cr&#244;nica, disfun&#231;&#227;o tireoidiana ou renal, gravidez, alcoolismo, tabagismo e aqueles usando drogas esteroides. Os restantes 41 pacientes (17 homens; idade entre 26 e 75 anos) com diagn&#243;stico definitivo para doen&#231;a de Chagas (dois diferentes testes sorol&#243;gicos com rea&#231;&#227;o positiva para o <italic>T cruzi</italic>) tinham hist&#243;ria, exame f&#237;sico e os seguintes exames normais: hemograma completo, horm&#244;nio estimulante da tireoide (TSH), T4 livre, glicose, pot&#225;ssio, ureia e creatinina. Todos os pacientes tinham o Holter de 24 horas livre de arritmias frequentes; ecocardiograma (ECO) normal ou alterado (entende-se como ECO alterado a presen&#231;a de qualquer altera&#231;&#227;o segmentar detect&#225;vel, mas com FE &gt; 50%); eletrocardiograma (ECG) de 12 deriva&#231;&#245;es normal ou alterado (entende-se por ECG alterado a presen&#231;a de bradicardia sinusal - FC &lt; 50 bpm, bloqueio completo ou incompleto de qualquer ramo, bloqueio atrioventricular em qualquer grau, extrass&#237;stoles ventriculares monom&#243;rficas ou polim&#243;rficas, &#225;rea eletricamente inativa e taquicardia ventricular n&#227;o sustentada); radiografia de t&#243;rax normal e aus&#234;ncia de isquemia mioc&#225;rdica e/ou arritmias ventriculares esfor&#231;o induzidas no teste ergom&#233;trico.</p>
    <p>Quarenta e quatro volunt&#225;rios sadios (nove homens, idade variando de 15 a 75 anos) foram os controles. Todos os controles e chag&#225;sicos examinados estavam em &#243;timas condi&#231;&#245;es f&#237;sica e mental, n&#227;o apresentam hist&#243;ria de sedentarismo, realizavam atividades regulares di&#225;rias, sem uso de qualquer f&#225;rmaco. Os pacientes chag&#225;sicos n&#227;o receberam tratamento especifico anti-<italic>T cruzi</italic>. O estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa (CEP) da institui&#231;&#227;o sob o n&#186; 233/09 e todos os pacientes assinaram um termo de consentimento livre e esclarecido em conformidade com a legisla&#231;&#227;o vigente e com as normas do CEP do HUCFF-UFRJ.</p>
    <p>Ambos os grupos foram submetidos &#224; avalia&#231;&#227;o da VRR por meio do teste de inclina&#231;&#227;o passiva, em sala climatizada e com isolamento ac&#250;stico, ap&#243;s jejum de quatro horas. O exame foi realizado ao longo de tr&#234;s etapas - ASR, repouso e inclina&#231;&#227;o passiva a 70&#176;. A primeira etapa consistiu em inspirar e expirar a 12 incurs&#245;es/minuto durante dois minutos, entre o 10&#176; e o 12&#176; minutos. A segunda etapa foi realizada em repouso - no qual a VRR foi analisada sem nenhum est&#237;mulo, entre o 15&#176; e o 20&#176; minutos. A terceira e &#250;ltima etapa iniciou-se no 20&#176; minuto, quando os pacientes foram inclinados passivamente a 70&#176; e os complexos foram avaliados at&#233; o 25&#176; minuto<sup>26</sup>.</p>
    <p>A VRR foi analisada no dom&#237;nio da frequ&#234;ncia. Foram avaliados a Alta Frequ&#234;ncia (AF) em termos percentuais - que representa o componente vagal do sistema nervoso aut&#244;nomo cardiovascular, e a rela&#231;&#227;o baixa/alta (rel B/A) - que expressa o balan&#231;o entre o componente simp&#225;tico e parassimp&#225;tico. A alta frequ&#234;ncia e a baixa frequ&#234;ncia foram medidas em unidades normatizadas, que indicam o valor relativo de cada componente em rela&#231;&#227;o ao poder total do espectro. A reserva vagal foi avaliada pelo aumento da AF em termos percentuais durante a ASR, comparando-a ao repouso. A modula&#231;&#227;o vagal perante o estimulo simp&#225;tico foi calculada pelo incremento na rela&#231;&#227;o B/A nos primeiros cinco minutos ap&#243;s inclina&#231;&#227;o passiva, comparada com o repouso - na qual grandes diferen&#231;as expressam melhor resposta.</p>
    <p>Apenas no soro de pacientes chag&#225;sicos foi pesquisada presen&#231;a de anticorpos circulantes funcionalmente ativos, contra receptores card&#237;acos acoplados &#224; prote&#237;na G (anti-m2 e anti-&#946;1) pelo m&#233;todo de Langendorf em cora&#231;&#245;es isolados de coelhos<sup>13</sup>. A presen&#231;a de anti-m2 foi definida quando ocorria, no experimento <italic>in vitro,</italic> uma diminui&#231;&#227;o de 10% da frequ&#234;ncia card&#237;aca sinusal em rela&#231;&#227;o ao controle ou algum grau de bloqueio intra-atrial ou atrioventricular, revertidos ap&#243;s adi&#231;&#227;o de atropina. A presen&#231;a de anti-&#946;1 foi definida quando ocorria, no experimento <italic>in vitro</italic>, um aumento de 5% na FC sinusal em rela&#231;&#227;o ao controle, revertido apos adi&#231;&#227;o de propranolol<sup>19,31</sup>.</p>
    <p>A separa&#231;&#227;o da fra&#231;&#227;o IgG com a&#231;&#227;o muscar&#237;nica e adren&#233;rgica foi feita por meio de purifica&#231;&#227;o em coluna de afinidade. A fra&#231;&#227;o IgG foi separada do soro dos pacientes por precipita&#231;&#227;o em (NH<sub>4</sub>)2SO<sub>4</sub> 50% e di&#225;lise extensiva contra PBS, pH 7,4, ao longo de 24 horas, a 4 &#186;C. A imunoglobulina assim preparada foi carregada numa coluna de gel de Sepharose 4B ativada com brometo de cianog&#234;nio (CNBr) (Pharmacia), a qual o pept&#237;dio correspondente &#224; segunda al&#231;a extracelular dos receptores (m2 ou &#946;1) foi covalentemente ligado. Ap&#243;s lavagem com PBS, a fra&#231;&#227;o da imunoglobulina que se ligou &#224; coluna foi elu&#237;da com tiocianato de pot&#225;ssio 3M (pH 7,4), seguida rapidamente de extensiva di&#225;lise contra PBS. Essa fra&#231;&#227;o assim obtida foi utilizada no cora&#231;&#227;o isolado de coelho para a caracteriza&#231;&#227;o do soro, seguindo as metodologias descritas acima<sup>13</sup>.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Para an&#225;lise estat&#237;stica foi usado o Stata software (vers&#227;o 8.0, 2003) e CIA software. Os valores da mediana com seus respectivos interquartis foram reportados devido &#224; distribui&#231;&#227;o assim&#233;trica dos dados. Vari&#225;veis foram comparadas pelo teste <italic>t</italic> de Student. N&#243;s tamb&#233;m apresentamos o intervalo de confian&#231;a 95% para as diferentes medianas. O valor de p &lt; 0,05 foi aceito como significante para toda an&#225;lise no estudo.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Foram avaliados 41 pacientes chag&#225;sicos (17 homens e 24 mulheres) e 44 controles (9 homens e 35 mulheres). No grupo chag&#225;sico, a idade oscilou entre 26 e 75 anos, mediana de 57 anos, e entre 15 e 75 anos no grupo controle, mediana de 38 anos. O n&#237;vel de atividade f&#237;sica foi similar entre os grupos. Os chag&#225;sicos apresentaram IMC m&#233;dio de 23,3, hemoglobina m&#233;dia de 13 g/dL e contagem m&#233;dia de leuc&#243;citos igual a 12,9 mil/mm<sup>3</sup>. Todos apresentavam TSH dentro da faixa da normalidade, com valor m&#233;dio de 2,92 mUI/L.</p>
    <p>Os achados mais frequentes encontrados no eletrocardiograma e ecocardiograma transtor&#225;cico dos pacientes chag&#225;sicos est&#227;o discriminados na <xref ref-type="table" rid="t1">Tabela 1</xref>. Apenas dois pacientes (4,9%) apresentaram disfun&#231;&#227;o leve - a FE m&#233;dia foi de 64,9% (Teicholz). Todos os pacientes do grupo controle apresentavam ECG normal. N&#227;o foi realizado ecocardiograma no grupo controle.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt01.jpg"/></table-wrap>
    <p>A avalia&#231;&#227;o da atividade parassimp&#225;tica por meio do componente de AF durante ASR demonstrou que os pacientes chag&#225;sicos com fun&#231;&#227;o de VE preservada s&#227;o capazes de expressar atividade parassimp&#225;tica durante a manobra da ASR, tendo-se o repouso como estado basal (<xref ref-type="fig" rid="aop_port06312f01">Figura 1</xref>). Entretanto, comparando os pacientes chag&#225;sicos aos controles, os primeiros manifestaram atividade parassimp&#225;tica significativamente menor em rela&#231;&#227;o aos &#250;ltimos (p=0,00002), expressando uma reduzida reserva vagal (<xref ref-type="table" rid="t2">Tabela 2</xref>). No grupo chag&#225;sico, durante a inclina&#231;&#227;o passiva a 70&#176;, houve uma eleva&#231;&#227;o da rela&#231;&#227;o B/A em rela&#231;&#227;o ao repouso ligeiramente superior &#224; observada nos controles (p = 0,01), com maior dispers&#227;o de valores conforme demonstrado na <xref ref-type="fig" rid="f2">Figura 2</xref>. Esse dado mostra que a disfun&#231;&#227;o parassimp&#225;tica tamb&#233;m se expressa na inclina&#231;&#227;o.</p>
    <p content-type="asset">
      <fig id="aop_port06312f01">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf01.jpg"/></fig>
    </p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt02.jpg"/></table-wrap>
    <fig id="f2">
      <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf02.jpg"/></fig>
    <p>Conforme a <xref ref-type="fig" rid="aop_port06312f03">Figura 3</xref>, os pacientes chag&#225;sicos foram analisados de acordo com a presen&#231;a de anticorpos acoplados &#224; prote&#237;na G (anti-m2 e anti-&#946;1) e subdivididos em quatro grupos: aus&#234;ncia de anticorpos (n = 11), presen&#231;a de anti-m2 puro (n = 2), presen&#231;a de anti-m2 associado a anti-&#946;1 (n=8) e, finalmente, presen&#231;a de anti-&#946;1 puro (n = 19). Observamos que pacientes que apresentaram apenas anticorpos anti-m2 ou anti-&#946;1 puros expressaram menor modula&#231;&#227;o vagal durante ASR. Entretanto, quando associados, esses promoveram um aumento da resposta vagal, comparados ao grupo de pacientes sem anticorpos.</p>
    <p content-type="asset">
      <fig id="aop_port06312f03">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf03.jpg"/></fig>
    </p>
    <p>Independentemente da presen&#231;a de altera&#231;&#245;es eletrocardiogr&#225;ficas, encontramos resposta similar quanto aos par&#226;metros de variabilidade RR medidos (<xref ref-type="table" rid="aop_port06312t03">Tabela 3</xref>). Do mesmo modo, o coeficiente de contig&#234;ncia entre ECG alterado e a identifica&#231;&#227;o de anticorpos com a&#231;&#227;o anti-m2 foi de 0,1388, mostrando que n&#227;o h&#225; associa&#231;&#227;o entre as vari&#225;veis.</p>
    <p content-type="asset">
      <table-wrap id="aop_port06312t03">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt03.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Em sintonia com estudos pr&#233;vios que abordaram pacientes chag&#225;sicos cr&#244;nicos com fun&#231;&#227;o ventricular preservada, o presente trabalho mostra que, ainda que persista uma atividade parassimp&#225;tica evocada pela arritmia sinusal respirat&#243;ria nesse grupo de pacientes, eles apresentam menor reserva vagal em rela&#231;&#227;o aos controles<sup>27-29,32</sup>. Essa redu&#231;&#227;o da reserva vagal n&#227;o foi acompanhada de altera&#231;&#227;o na frequ&#234;ncia card&#237;aca basal do paciente. O mais relevante e original resultado foi a observa&#231;&#227;o de que essa redu&#231;&#227;o esteve associada &#224; presen&#231;a de anticorpos funcionalmente ativos acoplados &#224; prote&#237;na G - particularmente anticorpos com a&#231;&#227;o anti-&#946;1. Esse achado foi independente da presen&#231;a de les&#245;es card&#237;acas estruturais, sugerindo que a modula&#231;&#227;o vagal possa estar condicionada a presen&#231;a de anticorpos.</p>
    <p>Embora sujeito a extensa investiga&#231;&#227;o, a causa da disfun&#231;&#227;o auton&#244;mica presente na miocardite chag&#225;sica cr&#244;nica n&#227;o tem sido ainda claramente estabelecida. V&#225;rios estudos demonstram que o processo inflamat&#243;rio est&#225; diretamente relacionado com a intensidade da resposta imunol&#243;gica tecidual<sup>33,34</sup>. Por sua vez, a liga&#231;&#227;o entre sistema nervoso aut&#244;nomo parassimp&#225;tico e o processo de regula&#231;&#227;o imunol&#243;gica foi sugerida h&#225; mais de 30 anos, quando foi notada atenua&#231;&#227;o da citotoxicidade do linf&#243;cito T pela estimula&#231;&#227;o colin&#233;rgica muscar&#237;nica<sup>35</sup>. Foram descritas vias de sinaliza&#231;&#227;o aferentes e eferentes que integram um arco reflexo, o reflexo "neuroimunol&#243;gico" ou reflexo "inflamat&#243;rio". Dessa forma, os dois sistemas (nervoso e imunol&#243;gico) podem se comunicar de forma bidirecional, utilizando como mediadores das informa&#231;&#245;es citocinas e neurotransmissores comuns aos dois sistemas. A via eferente do Sistema Nervoso Central (SNC) atua sobre o Sistema Imunol&#243;gico (SI) por meio do sistema nervoso parassimp&#225;tico, a denominada via anti-inflamat&#243;ria colin&#233;rgica. O SN parassimp&#225;tico inerva &#243;rg&#227;os do SI, e seu mediador acetilcolina age em c&#233;lulas do sistema imune, em especial nos macr&#243;fagos, via ativa&#231;&#227;o do receptor da acetilcolina<sup>36,37</sup>. De fato, a contribui&#231;&#227;o da regula&#231;&#227;o imunol&#243;gica na disautonomia foi hipotetizada mesmo em estudos iniciais dessa doen&#231;a devido &#224; bradicardia inapropriada presente nos pacientes chag&#225;sicos<sup>38</sup>. Um dos prov&#225;veis mecanismos &#233; a reatividade cruzada (mimetismo molecular)<sup>13</sup>.</p>
    <p>No presente estudo, foi poss&#237;vel observar que anticorpos circulantes funcionalmente ativos contra receptores card&#237;acos acoplados &#224; prote&#237;na G (anti-m2 e anti-&#946;1), quando associados, atuam de modo positivo na modula&#231;&#227;o parassimp&#225;tica, fato manifestado pelo aumento do componente de alta frequ&#234;ncia na an&#225;lise de VRR supostamente por uma intera&#231;&#227;o entre eles. Entretanto, a a&#231;&#227;o isolada de ambos promove menor modula&#231;&#227;o vagal, particularmente nos pacientes com anti-m2 isoladamente. Esses dados permite inferir uma rela&#231;&#227;o entre esses anticorpos e a modula&#231;&#227;o vagal. Em trabalhos pr&#233;vios, nosso grupo demonstrou que o soro de pacientes chag&#225;sicos cr&#244;nicos com a&#231;&#227;o muscar&#237;nica foi capaz de reduzir a FC e/ou gerar dist&#250;rbios de condu&#231;&#227;o atrioventricular no cora&#231;&#227;o isolado de coelho<sup>13-18,21</sup>. Recentemente, Ribeiro e cols. mostraram correla&#231;&#227;o entre altos n&#237;veis de anti-m2 detectados pelo m&#233;todo ELISA e redu&#231;&#227;o no componente de alta frequ&#234;ncia na analise de VRR (r = -0,32, p = 0,023)<sup>20</sup>. Os autores sugerem que essa disfun&#231;&#227;o vagal seja pelo efeito inibit&#243;rio do anti-m2, embasado no fen&#244;meno de dessensibiliza&#231;&#227;o.</p>
    <p>Outro achado no presente estudo &#233; a manuten&#231;&#227;o da frequ&#234;ncia card&#237;aca basal dos pacientes chag&#225;sicos apesar da redu&#231;&#227;o na reserva vagal. Essa manuten&#231;&#227;o da FC poderia ser justificada pela n&#227;o dessensibiliza&#231;&#227;o dos receptores muscarinicos m2. Em outras palavras, os anticorpos agonistas contra receptores card&#237;acos muscar&#237;nicos alteram a modula&#231;&#227;o vagal (&#237;ndices de VRR), mas n&#227;o o t&#244;nus vagal. Em trabalhos pr&#233;vios, mostramos que anticorpos presentes no soro de pacientes chag&#225;sicos cr&#244;nicos contra receptores muscar&#237;nicos m2 n&#227;o induziram uma dessensibiliza&#231;&#227;o dos receptores no cora&#231;&#227;o isolado de coelho<sup>13,14</sup>. A falta de dessensibiliza&#231;&#227;o dos receptores muscar&#237;nicos m2 n&#227;o &#233; particularmente surpreendente, j&#225; que ambos os ligantes (acetilcolina e IgG) possivelmente interagem em diferentes locais nos receptores situados na superf&#237;cie das c&#233;lulas do n&#243;dulo sinusal.</p>
    <p>Nosso grupo controle apresentou idade m&#233;dia inferior &#224; encontrada nos chag&#225;sicos. Esse efeito da idade na disfun&#231;&#227;o auton&#244;mica na doen&#231;a de Chagas ainda n&#227;o est&#225; bem claro. Resende e cols., comparando idosos saud&#225;veis, adultos jovens e idosos chag&#225;sicos, demonstraram n&#227;o haver diferen&#231;as na VRR entre os idosos ante os est&#237;mulos simp&#225;tico e parassimp&#225;tico. Uma justificativa aventada pelos autores seria a de que as altera&#231;&#245;es da senesc&#234;ncia j&#225; promoveriam resposta auton&#244;mica distinta, mascarando as altera&#231;&#245;es induzidas pela doen&#231;a de Chagas<sup>39</sup>.</p>
    <p>A maioria dos estudos dispon&#237;veis, realizada em v&#225;rios centros independentes, mostra que s&#227;o praticamente constantes as les&#245;es do sistema nervoso intracard&#237;aco, principalmente a agress&#227;o ao sistema parassimp&#225;tico<sup>39,40</sup>. Por outro lado, sabemos que o ECG alterado expressa comprometimento mioc&#225;rdio. Ent&#227;o, seria plaus&#237;vel supor que a disfun&#231;&#227;o auton&#244;mica (&#237;ndices de VRR) poderia ser secund&#225;ria a les&#227;o card&#237;aca estrutural. Neste estudo, n&#243;s mostramos que o ECG alterado n&#227;o esteve associado ao comprometimento da VRR, tornando essa hip&#243;tese menos prov&#225;vel. Villar e cols.<sup>25</sup> igualmente n&#227;o encontraram, dentre os pacientes com ECG alterado, diferen&#231;as no componente de AF em repouso. Tamb&#233;m, Rocha e cols.<sup>32</sup> mostram que a modula&#231;&#227;o auton&#244;mica (&#237;ndices de VRR) &#233; independente da disfun&#231;&#227;o ventricular card&#237;aca.</p>
    <p>A presen&#231;a de anticorpos circulantes funcionalmente ativos contra receptores card&#237;acos acoplados &#224; prote&#237;na G (anti-m2 e anti-&#946;1) em pacientes com doen&#231;a de Chagas &#233; um achado j&#225; estabelecido. Em estudos pr&#233;vios, nosso grupo e outros reportamos que esses anticorpos s&#227;o independentes de disfun&#231;&#227;o ventricular<sup>13,21,40</sup>. A busca por eventual correla&#231;&#227;o entre a presen&#231;a de anticorpos circulantes funcionalmente ativos contra receptores card&#237;acos acoplados &#224; prote&#237;na G (anti-m2 e anti-&#946;1) e altera&#231;&#245;es eletrocardiogr&#225;ficas, foi realizada por meio do coeficiente de conting&#234;ncia. O valor encontrado de 0,1388 torna pouco prov&#225;vel que o primeiro evento justifique o segundo.</p>
    <p>A avalia&#231;&#227;o da rela&#231;&#227;o baixa alta durante a inclina&#231;&#227;o permite observar a modula&#231;&#227;o do sistema simp&#225;tico sobre o vago. Embora em termos absolutos haja menor a&#231;&#227;o parassimp&#225;tica durante o est&#237;mulo ortost&#225;tico, como existe frequentemente um comprometimento concomitante do componente simp&#225;tico do SNA na doen&#231;a de Chagas, a rela&#231;&#227;o entre eles pode n&#227;o sofrer altera&#231;&#227;o na medida em que ambos est&#227;o reduzidos<sup>40</sup>. No presente trabalho, ela foi ligeiramente maior nos chag&#225;sicos em rela&#231;&#227;o aos controles, fato possivelmente justificado pela menor reserva vagal (representada pela AF que comp&#245;e o denominador da rela&#231;&#227;o).</p>
    <p>Relev&#226;ncia cl&#237;nica: A disfun&#231;&#227;o auton&#244;mica na doen&#231;a de Chagas pode estar envolvida no mecanismo de les&#227;o-repara&#231;&#227;o do cora&#231;&#227;o em diferentes situa&#231;&#245;es cl&#237;nicas. Pouco se conhece sobre os efeitos da estimula&#231;&#227;o da via anti-inflamat&#243;ria colin&#233;rgica sobre a modula&#231;&#227;o das arritmias card&#237;acas e morte s&#250;bita na doen&#231;a de Chagas. Os resultados do presente estudo poder&#227;o trazer importantes informa&#231;&#245;es a respeito da intera&#231;&#227;o do sistema nervoso aut&#244;nomo e sua rela&#231;&#227;o com o sistema imunol&#243;gico pela via anti-inflamat&#243;ria colin&#233;rgica, abrindo uma linha de investiga&#231;&#227;o que colocar&#225; a modula&#231;&#227;o farmacol&#243;gica da atividade vagal como alvo terap&#234;utico em diferentes modelos de les&#227;o-repara&#231;&#227;o do mioc&#225;rdio - com reflexo nas arritmias card&#237;acas e morte s&#250;bita. Contudo, at&#233; o presente momento, isso ainda tem sido muito mais uma hip&#243;tese te&#243;rica do que propriamente um fen&#244;meno clinico, e ainda necessita ser demonstrado.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>A menor reserva vagal em pacientes chag&#225;sicos com fun&#231;&#227;o preservada esteve associada &#224; presen&#231;a de anticorpos acoplados &#224; prote&#237;na G funcionalmente ativos, e n&#227;o &#224; presen&#231;a de les&#227;o card&#237;aca estrutural.</p>
    <p>Agradecemos &#224; Faperj e ao CNPq (Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico) o financiamento desta pesquisa.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de mestrado da Dra. Clarissa Antunes Thiers, pela UFRJ - ICES e INC.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <label>
          <bold> Correspond&#234;ncia:</bold>
        </label>
        <p>Roberto Coury Pedrosa </p>
        <p> Servi&#231;o de Cardiologia/ICES </p>
        <p> Hospital Universit&#225;rio Clementino Fraga Filho/UFRJ </p>
        <p> Rua Prof. Rodolpho Paulo Rocco, 255, Cidade Universit&#225;ria </p>
        <p> CEP 21941-913, Ilha do Fund&#227;o, RJ - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="coury@hucff.ufrj.br">coury@hucff.ufrj.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 08/01/12 </p>
    <p> Revisado em 12/01/12 </p>
    <p> Aceito em 10/02/12</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>01.  Engels D, Savioli L. Reconsidering the underestimated burden caused by neglected  tropical diseases. Trends Parasitol. 2006;22(8):363-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reconsidering the underestimated burden caused by neglected tropical diseases</article-title>
          <source>Trends Parasitol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>363</fpage>
          <lpage>6</lpage>
          <issue>8</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Engels</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Savioli</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>02.  Dias JCP. Globaliza&#231;&#227;o, iniq&#252;idade e doen&#231;a de Chagas.  Cad Sa&#250;de P&#250;blica, Rio de Janeiro. 2007;23(supl. 1):S13-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Globaliza&#231;&#227;o, iniq&#252;idade e doen&#231;a de Chagas</article-title>
          <source>Cad Sa&#250;de P&#250;blica, Rio de Janeiro</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>S13</fpage>
          <lpage>22</lpage>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dias</surname>
              <given-names>JCP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>03.  Mota EA, Guimar&#227;es AC, Santana OO, Sherlock I, Hoff R, Weller TH. A nine  year prospective study of Chagas' disease in a defined rural population in northeast  Brazil. Am J Trop Med Hyg. 1990;42(5):429-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A nine year prospective study of Chagas' disease in a defined rural population in northeast Brazil</article-title>
          <source>Am J Trop Med Hyg</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>429</fpage>
          <lpage>40</lpage>
          <issue>5</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mota</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>OO</given-names>
            </name>
            <name>
              <surname>Sherlock</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hoff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Weller</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>04.  Bestetti RB, Freitas OC, Muccillo G, Oliveira JS. Clinical and morphological characteristics  associated with sudden cardiac death in patients with Chagas' disease. Eur Heart  J. 1993;14(12):1610-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1610</fpage>
          <lpage>4</lpage>
          <issue>12</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bestetti</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Muccillo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>05.  Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol.  2001;76(1):75-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sudden death in Chagas' disease</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>75</fpage>
          <lpage>96</lpage>
          <issue>1</issue>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rassi</surname>
              <given-names>A Jr</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>06.  Sarabanda AV, Sosa E, Sim&#245;es MV, Figueiredo GL, Pintya AO, Marin-Neto JA.  Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic,  electrophysiologic and myocardial perfusion disturbances between patients presenting  with either sustained or nonsustained forms. Int J Cardiol. 2005;102(1):9-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>9</fpage>
          <lpage>19</lpage>
          <issue>1</issue>
          <volume>102</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sarabanda</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Sosa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sim&#245;es</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Figueiredo</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Pintya</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>07.  Xavier SS, Souza AS, do Brasil PEAA, Gabriel FG, de Holanda MT, Hasslocher-Moreno  A, et al. Incid&#234;ncia e preditores de morte s&#250;bita na cardiopatia  chag&#225;sica cr&#244;nica com fun&#231;&#227;o sist&#243;lica preservada.  Rev SOCERJ. 2005;18(5):457-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incid&#234;ncia e preditores de morte s&#250;bita na cardiopatia chag&#225;sica cr&#244;nica com fun&#231;&#227;o sist&#243;lica preservada</article-title>
          <source>Rev SOCERJ</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>457</fpage>
          <lpage>63</lpage>
          <issue>5</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Xavier</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>do Brasil</surname>
              <given-names>PEAA</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>de Holanda</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Hasslocher-Moreno</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>08.  Xavier SS, Haffner P, Souza AS, de Holanda MT, de Castro PHR, do Brasil PEAA,  Hasslocher-Moreno A. Mecanismo de morte e grau de acometimento mioc&#225;rdico  na fase cr&#244;nica da doen&#231;a de Chagas. Rev SOCERJ. 2007;20(2):133-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mecanismo de morte e grau de acometimento mioc&#225;rdico na fase cr&#244;nica da doen&#231;a de Chagas</article-title>
          <source>Rev SOCERJ</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>133</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Xavier</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Haffner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>de Holanda</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>de Castro</surname>
              <given-names>PHR</given-names>
            </name>
            <name>
              <surname>do Brasil</surname>
              <given-names>PEAA</given-names>
            </name>
            <name>
              <surname>Hasslocher-Moreno</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>09.  Sternick EB, Martinelli M, Sampaio R, Gerken LM, Teixeira RA, Scarpelli R, et  al. Sudden cardiac death in patients with chagas heart disease and preserved left  ventricular function. J Cardiovasc Electrophysiol. 2006;17(1):113-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>113</fpage>
          <lpage>6</lpage>
          <issue>1</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sternick</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gerken</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10.  Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. Predictors of all-cause  mortality for patients with chronic Chagas' heart disease receiving implantable  cardioverter defibrillator therapy. J Cardiovasc Electrophysiol. 2007;18(12):1236-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1236</fpage>
          <lpage>40</lpage>
          <issue>12</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cardinalli-Neto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bestetti</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>VC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11.  Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, et al.  Evaluation and treatment of chagas disease in the United States: a systematic  review. JAMA. 2007;298(18):2171-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation and treatment of chagas disease in the United States: a systematic review</article-title>
          <source>JAMA</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2171</fpage>
          <lpage>81</lpage>
          <issue>18</issue>
          <volume>298</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bern</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Herwaldt</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>A Jr</given-names>
            </name>
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dantas</surname>
              <given-names>RO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12.  Andrade JP, Marin Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al.  I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease:  executive summary. Arq Bras Cardiol. 2011;96(6):434-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>434</fpage>
          <lpage>42</lpage>
          <issue>6</issue>
          <volume>96</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Andrade</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Marin Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Paola</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Vilas-Boas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13.  de Oliveira SF, Pedrosa RC, Nascimento JH, Campos de Carvalho AC, Masuda MO. Sera  from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis  and conduction in isolated rabbit hearts. Circulation. 1997;96(6):2031-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts</article-title>
          <source>Circulation</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>2031</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>96</volume>
          <person-group person-group-type="author">
            <name>
              <surname>de Oliveira</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Campos de Carvalho</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>MO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14.  Masuda MO, Levin M, De Oliveira SF, Dos Santos Costa PC, Bergami PL, Dos Santos  Almeida NA, et al. Functionally active cardiac antibodies in chronic Chagas' disease  are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 1998;12(14):1551-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens</article-title>
          <source>FASEB J</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1551</fpage>
          <lpage>8</lpage>
          <issue>14</issue>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Masuda</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Levin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Oliveira</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Dos Santos Costa</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Bergami</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Dos Santos Almeida</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15.  Hernandez CC, Barcellos LC, Gimenez LE, Cabarcas RA, Garcia S, Pedrosa RC, et  al. Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type  Ca2+ currents. Cardiovasc Res. 2003;58(1):55-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type Ca2+ currents</article-title>
          <source>Cardiovasc Res</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>55</fpage>
          <lpage>65</lpage>
          <issue>1</issue>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hernandez</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Barcellos</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Gimenez</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Cabarcas</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16.  Retondaro FC, Dos Santos Costa PC, Pedrosa RC, Kurtenbach E. Presence of antibodies  against the third intracellular loop of the m2 muscarinic receptor in the sera  of chronic chagasic patients. FASEB J. 1999;13(14):2015-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Presence of antibodies against the third intracellular loop of the m2 muscarinic receptor in the sera of chronic chagasic patients</article-title>
          <source>FASEB J</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>2015</fpage>
          <lpage>20</lpage>
          <issue>14</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Retondaro</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Dos Santos Costa</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Kurtenbach</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17.  Medei E, Pedrosa RC, Benchimol Barbosa PR, Costa PC, Hernandez CC, Chaves EA,  et al. Human antibodies with muscarinic activity modulate ventricular repolarization:  basis for electrical disturbance. Int J Cardiol. 2007;115(3):373-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Human antibodies with muscarinic activity modulate ventricular repolarization: basis for electrical disturbance</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>373</fpage>
          <lpage>80</lpage>
          <issue>3</issue>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Medei</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Benchimol Barbosa</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chaves</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18.  Medei EH, Nascimento JH, Pedrosa RC, Carvalho AC. Role of autoantibodies in the  physiopathology of Chagas' disease. Arq Bras Cardiol. 2008;91(4):257-62, 281-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Role of autoantibodies in the physiopathology of Chagas' disease</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>257</fpage>
          <issue>4</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Medei</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19.  Sterin-Borda L, Borda E. Role of neurotransmitter autoantibodies in the pathogenesis  of chagasic peripheral dysautonomia. Ann N Y Acad Sci. 2000;917:273-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia</article-title>
          <source>Ann N Y Acad Sci</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>273</fpage>
          <lpage>80</lpage>
          <volume>917</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sterin-Borda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Borda</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20.  Ribeiro AL, Gimenez LE, Hernandez CC, de Carvalho AC, Teixeira MM, Guedes VC,  et al. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation  in Chagas disease. Int J Cardiol. 2007;117(1):59-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>59</fpage>
          <lpage>63</lpage>
          <issue>1</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Gimenez</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>de Carvalho</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Guedes</surname>
              <given-names>VC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21.  Altschuller MB, Pedrosa RC, Pereira BeB, Correa Filho WB, Medeiros AS, Costa PC,  et al. [Chronic Chagas disease patients with sinus node dysfunction: is the  presence of IgG antibodies with muscarinic agonist action independent of left  ventricular dysfunction?]. Rev Soc Bras Med Trop. 2007;40(6):665-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>[Chronic Chagas disease patients with sinus node dysfunction: is the presence of IgG antibodies with muscarinic agonist action independent of left ventricular dysfunction?]</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>665</fpage>
          <lpage>71</lpage>
          <issue>6</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Altschuller</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>BeB</given-names>
            </name>
            <name>
              <surname>Correa Filho</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22.  Landesmann MC, da Fonseca LM, de B Pereira B, do Nascimento EM, Rosado-de-Castro  PH, de Souza SA, et al. Iodine-123 metaiodobenzylguanidine cardiac imaging as  a method to detect early sympathetic neuronal dysfunction in chagasic patients  with normal or borderline electrocardiogram and preserved ventricular function.  Clin Nucl Med. 2011;36(9):757-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Iodine-123 metaiodobenzylguanidine cardiac imaging as a method to detect early sympathetic neuronal dysfunction in chagasic patients with normal or borderline electrocardiogram and preserved ventricular function</article-title>
          <source>Clin Nucl Med</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>757</fpage>
          <lpage>61</lpage>
          <issue>9</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Landesmann</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>da Fonseca</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>de B Pereira</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>do Nascimento</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Rosado-de-Castro</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>de Souza</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23.  Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, et al. Heart-rate  turbulence after ventricular premature beats as a predictor of mortality after  acute myocardial infarction. Lancet. 1999;353(9162):1390-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction</article-title>
          <source>Lancet</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1390</fpage>
          <lpage>6</lpage>
          <issue>9162</issue>
          <volume>353</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barthel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ulm</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rolnitzky</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24.  Bainbridge FA. The relation between respiration and the pulse-rate. J Physiol.  1920;54(3):192-202.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The relation between respiration and the pulse-rate</article-title>
          <source>J Physiol</source>
          <date>
            <year>1920</year>
          </date>
          <fpage>192</fpage>
          <lpage>202</lpage>
          <issue>3</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bainbridge</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25.  Villar JC, Leon H, Morillo CA. Cardiovascular autonomic function testing in asymptomatic  T. cruzi carriers: a sensitive method to identify subclinical Chagas' disease.  Int J Cardiol. 2004;93(2-3):189-95.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular autonomic function testing in asymptomatic T: cruzi carriers: a sensitive method to identify subclinical Chagas' disease</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>189</fpage>
          <lpage>95</lpage>
          <issue>2-3</issue>
          <volume>93</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Villar</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morillo</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26.  Junqueira LF Jr. A summary perspective on the clinical-functional significance  of cardiac autonomic dysfunction in Chagas' disease. Rev Soc Bras Med Trop. 2006;39(Suppl  3):64-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A summary perspective on the clinical-functional significance of cardiac autonomic dysfunction in Chagas' disease</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>64</fpage>
          <lpage>9</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Junqueira</surname>
              <given-names>LF Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27.  Correia D, Junqueira LF Jr, Molina RJ, Prata A. Cardiac autonomic modulation evaluated  by heart interval variability is unaltered but subtly widespread in the indeterminate  Chagas' disease. Pacing Clin Electrophysiol. 2007;30(6):772-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>772</fpage>
          <lpage>80</lpage>
          <issue>6</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Correia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Junqueira</surname>
              <given-names>LF Jr</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Prata</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28.  Ribeiro AL, de Carvalho AC, Lombardi F, Teixeira MM, Rocha MO. Enhanced parasympathetic  activity in Chagas disease still stands in need of proof. Int J Cardiol. 2009;135(3):406-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Enhanced parasympathetic activity in Chagas disease still stands in need of proof</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>406</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>135</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>de Carvalho</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>MO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29.  Vasconcelos DF, Junqueira LF Jr. Distinctive impaired cardiac autonomic modulation  of heart rate variability in chronic Chagas' indeterminate and heart diseases.  J Electrocardiol. 2009;42(3):281-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Distinctive impaired cardiac autonomic modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases</article-title>
          <source>J Electrocardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>281</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vasconcelos</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Junqueira</surname>
              <given-names>LF Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30.  Costa PC, Fortes FS, Machado AB, Almeida NA, Olivares EL, Cabral PR, et al. Sera  from chronic chagasic patients depress cardiac electrogenesis and conduction.  Braz J Med Biol Res. 2000;33(4):439-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sera from chronic chagasic patients depress cardiac electrogenesis and conduction</article-title>
          <source>Braz J Med Biol Res</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>439</fpage>
          <lpage>46</lpage>
          <issue>4</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Fortes</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Olivares</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31.  Goin JC, Borda E, Leiros CP, Storino R, Sterin-Borda L. Identification of antibodies  with muscarinic cholinergic activity in human Chagas' disease: pathological implications.  J Auton Nerv Syst. 1994;47(1-2):45-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications</article-title>
          <source>J Auton Nerv Syst</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <issue>1-2</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Goin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Borda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Leiros</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Storino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sterin-Borda</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32.  Rocha AL, Lombardi F, da Costa Rocha MO, Barros MV, Val Barros VdaC, Reis AM,  et al. Chronotropic incompetence and abnormal autonomic modulation in ambulatory  Chagas disease patients. Ann Noninvasive Electrocardiol. 2006;11(1):3-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients</article-title>
          <source>Ann Noninvasive Electrocardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>3</fpage>
          <lpage>11</lpage>
          <issue>1</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rocha</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>da Costa Rocha</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Val Barros</surname>
              <given-names>VdaC</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33.  Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between  heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology.  2008;33(10):1305-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The relationship between heart rate variability and inflammatory markers in cardiovascular diseases</article-title>
          <source>Psychoneuroendocrinology</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1305</fpage>
          <lpage>12</lpage>
          <issue>10</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Haensel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Nelesen</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Dimsdale</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34.  Owen N, Steptoe A. Natural killer cell and proinflammatory cytokine responses  to mental stress: associations with heart rate and heart rate variability. Biol  Psychol. 2003;63(2):101-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Natural killer cell and proinflammatory cytokine responses to mental stress: associations with heart rate and heart rate variability</article-title>
          <source>Biol Psychol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>101</fpage>
          <lpage>15</lpage>
          <issue>2</issue>
          <volume>63</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Owen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Steptoe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35.  Strom TB, Deisseroth A, Morganroth J, Carpenter CB, Merrill JP. Alteration of  the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators  of adenylate cyclase. Proc Natl Acad Sci U S A. 1972;69(10):2995-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <date>
            <year>1972</year>
          </date>
          <fpage>2995</fpage>
          <lpage>9</lpage>
          <issue>10</issue>
          <volume>69</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Strom</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Deisseroth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morganroth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Merrill</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36.  Blalock JE. The immune system as a sensory organ. J Immunol. 1984;132(3):1067-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The immune system as a sensory organ</article-title>
          <source>J Immunol</source>
          <date>
            <year>1984</year>
          </date>
          <fpage>1067</fpage>
          <lpage>70</lpage>
          <issue>3</issue>
          <volume>132</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Blalock</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37.  Blalock JE. The immune system as the sixth sense. J Intern Med. 2005;257(2):126-38.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The immune system as the sixth sense</article-title>
          <source>J Intern Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>126</fpage>
          <lpage>38</lpage>
          <issue>2</issue>
          <volume>257</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Blalock</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38.  Chagas C, Villela E. Forma card&#237;aca da Trypanosom&#237;ase Americana.  Mem Inst Osvaldo Cruz. 1922;14:5-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Forma card&#237;aca da Trypanosom&#237;ase Americana</article-title>
          <source>Mem Inst Osvaldo Cruz</source>
          <date>
            <year>1922</year>
          </date>
          <fpage>5</fpage>
          <lpage>61</lpage>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chagas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Villela</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39.  de Resende LA, Molina RJ, Ferreira BD, Carneiro AC, Ferreira LA, da Silva VJ,  et al. Cardiac autonomic function in chagasic elderly patients in an endemic area:  a time and frequency domain analysis approach. Auton Neurosci. 2007;131(1-2):94-101.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac autonomic function in chagasic elderly patients in an endemic area: a time and frequency domain analysis approach</article-title>
          <source>Auton Neurosci</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>94</fpage>
          <lpage>101</lpage>
          <issue>1-2</issue>
          <volume>131</volume>
          <person-group person-group-type="author">
            <name>
              <surname>de Resende</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>VJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40.  Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM. Levels  of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart  dysfunction in Chagas' heart disease. Microbes Infect. 2006;8(9-10):2459-64.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease</article-title>
          <source>Microbes Infect</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2459</fpage>
          <lpage>64</lpage>
          <issue>9-10</issue>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Talvani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Borda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sterin-Borda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Autonomic dysfunction and anti-M2 and anti-&#946;1 receptor antibodies in Chagas disease patients</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Sudden death is the leading cause of death in Chagas' disease, affecting patients even in the early stages of the disease. The impairment of the autonomic nervous system in this disease has been recognized, as well as its potential as a trigger for malignant arrhythmias when associated with structural or metabolic changes. OBJECTIVE: We sought to identify, in Chagas patients with preserved systolic function, the impairment of the autonomic nervous system and its association with functionally active anti-m2 and anti-&#946;1 receptor antibodies. METHODS: Using spectral analysis of RR variability during passive tilt test, chronic chagasic patients were compared with healthy controls matched for age. Subsequently, the association of autonomic dysfunction with functionally active antibodies with anti-m2 and anti-&#946;1 action was investigated by the Langendorf method. RESULTS: We observed that patients with Chagas disease without ventricular dysfunction express parasympathetic activity against a vagal stimulus, however with less intensity compared to controls. Chagasic patients with anti-m2 or anti-&#946;1 antibodies showed a further significant reduction of the vagal response during respiratory sinus arrhythmia, regardless of the presence of structural lesion. However, the association of both factors promoted response to vagal stimulation similar to that seen in Chagas disease without their presence. CONCLUSION: The lower vagal reserve in Chagas patients with preserved function was associated with functionally active anti-m2 or anti-&#946;1 antibodies, and not with the presence of structural heart lesion.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Chagas disease</kwd>
        <kwd>autonomic denervation</kwd>
        <kwd>antibodies</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Autonomic dysfunction and anti-M2 and anti-</bold>
          </label>
          <p>
            <bold>&#946;</bold>
          </p>
          <p>
            <bold>1 receptor antibodies in Chagas Disease patients</bold>
          </p>
        </fn>
      </p>
      <p>
        <bold>Clarissa Antunes Thiers<sup>I, II</sup>; Jo&#227;o Luis Barbosa<sup>I, II</sup>; Bas&#237;lio de Bragan&#231;a Pereira<sup>II, IV</sup>; Em&#237;lia Matos do Nascimento<sup>III</sup>; Jos&#233; Hamilton do Nascimento<sup>V</sup>; Emiliano Hor&#225;cio Medei<sup>V</sup>; Roberto Coury Pedrosa<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Instituto Nacional de Cardiologia - Rio de Janeiro, RJ - Brazil</p>
      <p><sup>II</sup>Servi&#231;o de Cardiologia, Hospital Universit&#225;rio Clementino Fraga Filho / Instituto de Cardiologia Edson Saad - UFRJ - Rio de Janeiro, RJ - Brazil</p>
      <p><sup>III</sup>Instituto Alberto Luiz Coimbra de P&#243;s-Gradua&#231;&#227;o e Pesquisa de Engenharia, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brazil</p>
      <p><sup>IV</sup>Servi&#231;o de Bioestat&#237;stica e Estat&#237;stica Aplicada, Faculdade de Medicina, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brazil</p>
      <p><sup>V</sup>Instituto de Biof&#237;sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro - Rio de Janeiro, RJ - Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Sudden death is the leading cause of death in Chagas' disease, affecting patients even in the early stages of the disease. The impairment of the autonomic nervous system in this disease has been recognized, as well as its potential as a trigger for malignant arrhythmias when associated with structural or metabolic changes.</p>
      <p><bold>OBJECTIVE: </bold> We sought to identify, in Chagas patients with preserved systolic function, the impairment of the autonomic nervous system and its association with functionally active anti-m2 and anti-&#946;1 receptor antibodies.</p>
      <p><bold>METHODS: </bold> Using spectral analysis of RR variability during passive tilt test, chronic chagasic patients were compared with healthy controls matched for age. Subsequently, the association of autonomic dysfunction with functionally active antibodies with anti-m2 and anti-&#946;1 action was investigated by the Langendorf method.</p>
      <p><bold>RESULTS: </bold> We observed that patients with Chagas disease without ventricular dysfunction express parasympathetic activity against a vagal stimulus, however with less intensity compared to controls. Chagasic patients with anti-m2 or anti-&#946;1 antibodies showed a further significant reduction of the vagal response during respiratory sinus arrhythmia, regardless of the presence of structural lesion. However, the association of both factors promoted response to vagal stimulation similar to that seen in Chagas disease without their presence.</p>
      <p><bold>CONCLUSION: </bold> The lower vagal reserve in Chagas patients with preserved function was associated with functionally active anti-m2 or anti-&#946;1 antibodies, and not with the presence of structural heart lesion.</p>
      <p><bold>Keywords:</bold> Chagas disease; autonomic denervation; antibodies.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>One hundred years after its description by Carlos Chagas in 1909, Chagas Disease (CD) remains a challenge to Health Organizations. According to the World Health Organization (WHO), although the vector transmission has been interrupted in countries such as Brazil, Chile and Uruguay, the prevalence of patients with chronic Chagas disease was estimated at 18 to 20 million individuals in Latin America, with 300,000 new cases each year and 50,000 deaths a year associated with the disease<sup>1</sup>. In Brazil, chronic disease cases currently predominate, with approximately three million infected individuals<sup>2</sup>.</p>
      <p>There is not enough evidence to support the need for immediate treatment in all chronic chagasic patients with preserved function, although there are studies suggesting an increase in morbidity and mortality in this group of patients<sup>3-11</sup>. A recent review has suggested that in patients with this form of heart disease (ECG alterations and regional alterations in the echocardiogram, but with preserved ventricular function), the need for further evaluation should be judged on an individual basis<sup>11</sup>. The I Latin American Guidelines for the diagnosis and treatment of Chagasic cardiopathy, recently published, also recognizes the existence of this group of patients and its prognostic value for sudden death<sup>12</sup>.</p>
      <p>In recent decades, several studies have elucidated an association between the Autonomic Nervous System (ANS) and immune function, and have helped to disclose some mechanisms involved in this interaction. Our group has had active participation in relation to chronic chagasic cardiopathy<sup>13-18</sup>. It is possible that functionally active circulating antibodies against G protein-coupled receptors, capable of interfering with receptors of both, parasympathetic and sympathetic systems, can physiologically affect the cardiac autonomic behavior and modulate electrophysiological properties involved in mechanisms of complex ventricular arrhythmias<sup>18-20</sup>. These antibodies are not just epiphenomenon of the destruction of the autonomic nervous system and are independent from cardiac lesions<sup>14,20-23</sup>. We recently showed that in chagasic patients with preserved systolic function, cardiac sympathetic autonomic modulation is affected. This was demonstrated by cardiac nerve destruction that occurred in the ventricular context demonstrated by <sup>123</sup>I-MIBG<sup>23</sup>.</p>
      <p>Studies of RR variability (RRV) have been established as a real and reproducible marker of cardiovascular autonomic function<sup>24</sup>. Among the maneuvers to assess the parasympathetic response, the Respiratory Sinus Arrhythmia (RSA) has been shown to be the most potent stimulus to evoke vagus nerve action<sup>25,26</sup>. In Chagas disease, in the group with no ventricular dysfunction, the evaluation of the autonomic nervous system through the RRV by different methods has shown variable impairment of parasympathetic and sympathetic modulation<sup>27-30</sup>. The present study aims to identify, in patients with Chagas disease without ventricular dysfunction, those with alterations in vagal autonomic modulation on the RRV in response to the RSA and at the physiological sympathetic stimulation maneuver (passive tilt at 70&#176;), and correlate it to the presence of functionally active antibodies against cardiac muscarinic m2 and adrenergic &#946;1 receptors.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This is a case series study carried out between October/2009 and August/2010. Patient selection was performed at the chagasic cardiopathy outpatient clinic of Hospital Universit&#225;rio Clementino Fraga Filho - UFRJ / HUCFF. Of 310 regularly monitored individuals, 76 patients whose sera were characterized for the presence of functionally active antibodies against G-protein coupled receptors (anti-m2 and/or anti-&#946;1) were selected. The study excluded 35 patients with chronic diseases, especially cardiovascular ones; those with ejection fraction (EF) &lt; 50%; frequent cardiac arrhythmias and/or non-sinus rhythms; diabetes mellitus, Parkinson's disease or any neuropathy; patients on medications that could interfere with the cardiovascular system; chronic obstructive pulmonary disease, kidney or thyroid dysfunction, pregnancy, alcoholism, smoking and those using steroid drugs.</p>
      <p>The remaining 41 patients (17 men, aged between 26 and 75 years) with a definite diagnosis of Chagas disease (two different serological tests with positive reaction to <italic>T. cruzi</italic>) had normal history, physical examination and the following tests: CBC, thyroid-stimulating hormone (TSH), free-T4, glucose, potassium, urea and creatinine. All patients had 24-hour Holter monitoring free of frequent arrhythmias, normal or abnormal echocardiography (ECHO) (with abnormal ECHO understood as the presence of any detectable segmental alteration, but with EF &gt; 50%), normal or abnormal 12-lead electrocardiogram (ECG) (with abnormal ECG defined by the presence of sinus bradycardia - HR &lt; 50 bpm, complete or incomplete block of any branch, any degree of atrioventricular block, monomorphic or polymorphic ventricular extrasystoles, electrically inactive area and nonsustained ventricular tachycardia); normal chest x-ray and absence of myocardial ischemia and/or stress-induced ventricular arrhythmias during exercise test.</p>
      <p>Forty-four healthy volunteers (nine men, aged 15-75 years) were controls. All controls and chagasic patients assessed were in good physical and mental shape, had no history of sedentary lifestyle and performed regular daily activities, without any drugs. Chagasic patients did not receive specific anti<italic>-T. cruzi</italic> therapy. The study was approved by the Ethics Committee in Research (ECR) of the institution under No. 233/09 and all patients signed an informed consent form in accordance with current Brazilian law and the rules of the ECR of HUCFF-UFRJ.</p>
      <p>Both groups were evaluated for RRV through passive tilt test, in an air-conditioned and soundproof room, after fasting for four hours.</p>
      <p>The test was performed in three stages - RSA, rest and passive tilt at 70&#176;. The first step was to inhale and exhale at 12 breaths/minute for two minutes between the 10<sup>th</sup> and 12<sup>th</sup> minutes. The second step was performed at rest - in which the RRV was analyzed without any stimulus, between the 15<sup>th</sup> and 20<sup>th</sup> minutes. The third and last phase began in the 20<sup>th</sup> minute, when patients were passively tilted at 70&#176; and the complexes were evaluated until the 25<sup>th</sup> minute<sup>26</sup>.</p>
      <p>The RRV was analyzed in the frequency domain. We evaluated the High Frequency (HF) in percentage terms - which represents the vagal component of the cardiovascular autonomic nervous system, and the low/high ratio (L/H ratio) - which expresses the balance between the sympathetic and parasympathetic components. The high frequency and the low frequency were measured in normalized units that indicate the relative value of each component relative to the total power of the spectrum. The vagal reserve was assessed by the increase in HF in percentage terms during the RSA, comparing it to rest. The vagal stimulation in the presence of the sympathetic stimulus was calculated by the increase in the L/H ratio in the first five minutes after passive inclination, compared with rest - in which great differences express a better response.</p>
      <p>The presence of functionally active circulating antibodies against G-protein coupled cardiac receptors (anti-M2 and anti-&#946;1) was investigated only in the serum of patients with Chagas disease using the Langendorf method in isolated rabbit hearts<sup>13</sup>. The presence of anti-M2 was defined when a 10% reduction in the sinus heart rate occurred <italic>in vitro</italic>, as compared to control or some degree of intra-atrial or atrioventricular block reversed after atropine addition. The presence of anti-&#946;1 was defined when a 5% increase in sinus HR occurred in vitro compared to control, reversed after addition of propranolol<sup>19,31</sup>.</p>
      <p>The separation of the IgG fraction with adrenergic and muscarinic action was performed by affinity column purification. The IgG fraction was separated from the serum of patients by precipitation in (NH<sub>4</sub>) 2SO<sub>4</sub> at 50% and extensive dialysis against PBS, pH 7.4, during 24 hours at 4 &#186;C. Immunoglobulin thus prepared was loaded onto a column of Sepharose 4B gel activated with cyanogen bromide (CNBr) (Pharmacia), to which the peptide corresponding to the second extracellular loop of the receptor (m2 or &#946;1) was covalently bonded. After washing with PBS, the fraction of the immunoglobulin that bound to the column was eluted with 3M potassium thiocyanate (pH 7.4), quickly followed by extensive dialysis against PBS. This fraction thus obtained was used in the isolated rabbit heart to characterize the serum, following the methodology described above<sup>13</sup>.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Statistical analysis was performed using the Stata software (release 8.0, 2003) and CIA software. Medians and their respective interquartile values were reported due to the asymmetrical distribution of data. Variables were compared by Student's <italic>t</italic> test. We also present the 95% confidence interval for the different medians. A p value &lt; 0.05 was considered significant for all analyses in the study.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>We evaluated 41 patients with Chagas disease (17 men and 24 women) and 44 controls (9 men and 35 women). In the chagasic group, age ranged between 26 and 75 years, median of 57 years and in the control group it ranged between 15 and 75 years, with a median of 38 years. The level of physical activity was similar between groups. Chagasic patients had a mean BMI of 23.3, mean hemoglobin of 13 g/dL and mean leukocyte count of 12.9 mil/mm<sup>3</sup>. All had TSH levels within the normal range, with a mean value of 2.92 mIU/L.</p>
      <p>The most common findings observed in the electrocardiogram and transthoracic echocardiogram of patients with Chagas disease are shown in <xref ref-type="table" rid="t1-body2">Table 1</xref>. Only two patients (4.9%) had mild dysfunction - the mean ejection fraction was 64.9% (Teicholz). All control patients had normal ECG. Echocardiography was not performed in the control group.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt01-en.jpg"/></table-wrap>
      <p>The assessment of parasympathetic activity through the HF component during RSA demonstrated that chagasic patients with preserved LV function are able to express parasympathetic activity during the RSA maneuver, with resting as the basal state (<xref ref-type="fig" rid="aop_ing06312f01-body2">Figure 1</xref>). However, when comparing chagasic patients with controls, the first expressed significantly lower parasympathetic activity when compared to the latter (p = 0.00002), expressing a reduced vagal reserve (<xref ref-type="table" rid="aop_ing06312t02-body2">Table 2</xref>). In chagasic group during passive tilt at 70&#176;, there was an increase in the L/H ratio in relation to rest that was slightly higher than the one observed in the controls (p = 0.01), with higher dispersion values as shown in <xref ref-type="fig" rid="f2-body2">Figure 2</xref>. These data show that parasympathetic dysfunction is also expressed in the slope.</p>
      <p content-type="asset">
        <fig id="aop_ing06312f01-body2">
          <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf01-en.jpg"/></fig>
      </p>
      <p content-type="asset">
        <table-wrap id="aop_ing06312t02-body2">
          <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt02-en.jpg"/></table-wrap>
      </p>
      <fig id="f2-body2">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf02-en.jpg"/></fig>
      <p>According to <xref ref-type="fig" rid="f3-body2">Figure 3</xref>, chagasic patients were analyzed according to the presence of G protein-coupled antibodies (anti-M2 and anti-&#946;1) and divided into four groups: no antibodies (n = 11), presence of anti-M2 alone (n =2) presence of anti-M2 associated with anti-&#946;1 (n = 8) and, finally, the presence of anti-&#946;1 alone (n = 19). We observed that patients who had only anti-m2 or anti-&#946;1 showed lower vagal modulation during RSA. However, when associated, they promoted an increase in the vagal response, when compared to patients with no antibodies.</p>
      <fig id="f3-body2">
        <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gf03-en.jpg"/></fig>
      <p>Regardless of the presence of electrocardiographic alterations, we found a similar response regarding the RR variability parameters observed (<xref ref-type="table" rid="aop_ing06312t03-body2">Table 3</xref>). Similarly, the coefficient of contingency between abnormal ECG and identification of anti-M2 antibodies was 0.1388, indicating that there is no association between variables.</p>
      <p content-type="asset">
        <table-wrap id="aop_ing06312t03-body2">
          <graphic xlink:href="1678-4170-abc-99-02-0732-00067-gt03-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>In agreement with previous studies that addressed chronic Chagas patients with preserved ventricular function, this study shows that, whereas there is still parasympathetic activity evoked by respiratory sinus arrhythmia in this group of patients, they have lower vagal reserve in relation to controls<sup>27-29,32</sup>. This reduction in vagal reserve was not accompanied by changes in basal heart rate of the patient. The most important and original result was the observation that this reduction was associated with the presence of protein G-coupled functionally active antibodies - particularly anti-&#946;1 antibodies. This finding was independent from the presence of structural heart damage, suggesting that the vagal modulation can be subject to the presence antibodies.</p>
      <p>Although subject to extensive research, the cause of this autonomic dysfunction in chronic chagasic myocarditis has yet to be clearly established. Several studies have shown that the inflammatory process is directly related to the intensity of the tissue immune response <sup>33,34</sup>. In turn, the association between the parasympathetic autonomic nervous system and immune regulation process was suggested over 30 years ago, when the T-lymphocyte cytotoxicity attenuation by muscarinic cholinergic stimulation was observed<sup>35</sup>. Afferent and efferent signaling pathways that integrate a reflex arc were described, the "neuroimmunological" or "inflammatory" reflex. Thus, the two systems (nervous and immune systems) can communicate bidirectionally using cytokines and neurotransmitters common to both systems as information mediators.</p>
      <p>The efferent pathway of the Central Nervous System (CNS) acts on the immune system (IS) through the parasympathetic nervous system, the so-called anti-inflammatory cholinergic pathway. The parasympathetic nervous system innervates organs of the IS and its mediator acetylcholine acts on immune cells, particularly macrophages, via activation of acetylcholine receptor<sup>36,37</sup>. In fact, the contribution of immune regulation in dysautonomia has been hypothesized even in early studies of this disease due to inappropriate bradycardia present in patients with Chagas disease<sup>38</sup>. One of the possible mechanisms is the cross-reactivity (molecular mimicry)<sup>13</sup>.</p>
      <p>In this study, we observed that functionally active G-protein coupled circulating antibodies against cardiac receptors (anti-m2 and anti-1), when combined, act positively in parasympathetic modulation, a fact demonstrated by increase in the high frequency component the RRV analysis, supposedly due to an interaction between them. However, the isolated action of both promotes lower vagal modulation, particularly in patients with anti-m2 alone. These data allow us to infer an association between these antibodies and vagal modulation. In earlier studies, our group demonstrated that serum from chronic Chagasic patients with muscarinic action was able to reduce the HR and/or generate atrioventricular conduction disturbances in isolated rabbit hearts<sup>13-18,21</sup>. Recently, Ribeiro et al. showed a correlation between high levels of anti-m2 detected by ELISA and a decrease in the high frequency component at the RRV analysis (r = -0.32, p = 0.023)<sup>20</sup>. The authors suggest that this vagal dysfunction is caused by the inhibitory effect of anti-m2, based on the desensitization phenomenon.</p>
      <p>Another finding in this study is the maintenance of basal heart rate in patients with Chagas disease despite a reduction in vagal reserve. This HR maintenance could not be justified by the lack of desensitization of m2-muscarinic receptors. In other words, the agonist antibodies against cardiac muscarinic receptors alter the vagal modulation (RRV index), but not the vagal tone. In previous studies, we showed that antibodies present in the serum of chronic chagasic patients against m2-muscarinic receptors did not induce receptor desensitization in isolated rabbit hearts<sup>13,14</sup>.</p>
      <p>The lack of desensitization of the m2 muscarinic receptors is not particularly surprising, as both ligands (acetylcholine and IgG) possibly interact in different locations in the receptors situated on the surface of the sinus node cells.</p>
      <p>The mean age in our control group was lower than that found in chagasic patients. This effect of age on autonomic dysfunction in Chagas' disease is yet to be clarified. Resende et al., comparing healthy elderly individuals, young adults and elderly chagasic patients showed no difference in RRV between the elderly in the presence of sympathetic and parasympathetic stimuli. One reason suggested by the authors would be that the senescence alterations would promote a distinct autonomic response, masking the alterations induced by Chagas disease <sup>39</sup>.</p>
      <p>Most available studies, performed in several independent centers, show that intracardiac nervous system lesions are practically constant, especially the parasympathetic system aggression<sup>39,40</sup>. On the other hand, we know that the abnormal ECG shows infarction. So it is plausible to suppose that the autonomic dysfunction (RRV rates) could be secondary to the structural cardiac injury. In this study, we show that the abnormal ECG was not associated with RRV impairment, making this hypothesis less likely. Villar et al.<sup>25</sup> did not find, among patients with ECG alterations, differences in the HF component at rest. Moreover, Rocha et al.<sup>32</sup> showed that the autonomic modulation (RRV index) is independent from the cardiac ventricular dysfunction.</p>
      <p>The presence of functionally active circulating antibodies against G-protein coupled cardiac receptors (anti-m2 and anti-&#946;1) in patients with Chagas' disease is an already established finding. In previous studies, our group and others reported that these antibodies are independent from ventricular dysfunction<sup>13,21,40</sup>. The search for a possible correlation between the presence of functionally active circulating antibodies against cardiac receptors coupled to G protein (anti-m2 and anti-&#946;1) and electrocardiographic alterations was performed using the contingency coefficient. The obtained value of 0.1388 makes it unlikely that the first event justifies the second.</p>
      <p>The evaluation of the low/high ratio during the tilt test allows the observation of the sympathetic modulation on the vagus system. Although in absolute terms there is less parasympathetic action during the orthostatic stimulus, as there is often a concomitant involvement of the sympathetic component of the SNA in Chagas' disease, the association between them may not be altered as they are both decreased<sup>40</sup>. In this study, it was slightly higher in chagasic patients than in controls, a fact possibly explained by the lower vagal reserve (represented by HF that comprises the ratio denominator). <italic>Clinical</italic> r<italic>elevance</italic>: Autonomic dysfunction in Chagas' disease can be involved in the injury-repair mechanism of the heart in different clinical situations. Little is known on the stimulation effects of the anti-inflammatory cholinergic pathway on the modulation of cardiac arrhythmias and sudden death in Chagas' disease. The results from this study can provide important information on the interaction of the autonomic nervous system and its relationship with the immune system through the cholinergic anti-inflammatory pathway, opening a line of research that will establish the pharmacological modulation of vagal activity as a therapeutic target in different models of myocardial injury-repair - with an effect on cardiac arrhythmias and sudden death. However, to date, it has been very much a theoretical hypothesis than a clinical phenomenon, and still needs to be demonstrated.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>The lower vagal reserve in Chagas patients with preserved function was associated with the presence of functionally active G-protein coupled antibodies, but not with the presence of structural heart lesion.</p>
      <p>We thank FAPERJ and CNPq (National Council for Scientific and Technological Development) for funding this research.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Dra. Clarissa Antunes Thiers from UFRJ - ICES e INC.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
